Navigation Links
Laureate Biopharma to Produce Biosimilar Product for Leading Generics Company
Date:7/25/2011

PRINCETON, N.J., July 25, 2011 /PRNewswire/ -- Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced that they have entered into a multi-year development and manufacturing agreement with a leading generic pharmaceutical company to produce a biosimilar product.  Laureate's services will include transfer of the manufacturing process to Laureate and cGMP manufacture of this product for clinical trials through 2013. The agreement includes a customer option for long-term commercial supply.  Laureate expects to supply the first batch of clinical product during the first half of 2012.  Terms of the manufacturing agreement were not disclosed.

"Biosimilars are the immediate growth engine of the generic industry and we are pleased to be working with one of the leading generic companies in the world on this product," said Michael A. Griffith, CEO of Laureate Biopharma. "Manufacture of biosimilars is one natural extension of Laureate's existing portfolio of contract manufacturing services and represents a key strategic step for the company."  

About Biosimilars

Biosimilars are subsequent versions of recombinant therapeutic innovator products manufactured and sold by a different corporate sponsor following expiry of patent exclusivity for the innovator product.  With many innovator biopharmaceutical products going off patent in the next 5-10 years, there is an industry-wide effort to develop corresponding biosimilars. The U.S. FDA was given the authority to approve biosimilars within the Patient Protection and Affordable Care Act of 2010, following similar approvals in the European Union.  

About Laureate Biopharmaceutical Services, Inc.

Laureate Biopharmaceutical Services, Inc. is a full-service biopharmaceutical contract development and manufacturing organization. Laureate Biopharma's scientists are expert
'/>"/>

SOURCE Laureate Biopharmaceutical Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Laureates Electronic Submission Gateway Approved
2. Laureate Pharma Changes Name to Laureate Biopharmaceutical Services, Inc.
3. Laureate Pharma Launches New Regulatory Affairs Services and Appoints Robert G. Burford, Ph.D., as Vice President
4. Laureate Pharma Announces New Development and Manufacturing Agreement to Produce AVEO Pharmaceuticals Antibody Therapeutic
5. Elsevier Celebrates Nine 2010 Nobel Laureates and Honors Achievements With Freely Available Prize-Winning Research
6. Laureate Pharma Secures $20 Million to Enhance and Grow Biopharmaceutical Contract Manufacturing Business
7. Laureate Pharma Appoints Steven R. Johnson as Vice President, Business Development
8. Thomson Reuters Predicts Nobel Laureates
9. Laureate Pharma Announces Signing New Biopharmaceutical Development & Manufacturing Agreement
10. Nobel Laureate Dr. Gunter Blobel to Speak at Florida Atlantic University
11. Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty ... disease and overall health is pleased to provide you with ... outlook for 2015 from the CEO, Mr. Eugene Bortoluzzi ... like to take this opportunity to share with you the ...
(Date:1/22/2015)... SAN DIEGO , Jan. 22, 2015  Profil Institute ... focused on diabetes and obesity, announced today a new ... Drug Development,  published by Springer, a leading global scientific ... extensively analyze and illustrate techniques for use in early ...
(Date:1/22/2015)... Research and Markets ( http://www.researchandmarkets.com/research/x3hp3g/microbiology ) ... Testing/Clinical Microbiology Market by Product, Clinical Application & ... report to their offering. Clinical microbiology ... the detection of infectious diseases. The respiratory diseases ...
Breaking Medicine Technology:Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 2Global Microbiology Testing/Clinical Microbiology (Instrument, Analyzer, Incubator, Kit, Microscope, Molecular Diagnostics) Market - Forecast to 2019 3
... The Pharmaceutical,Research and Manufacturers of America (PhRMA) ... pipeline for major diseases affecting African,Americans to Mississippi ... pharmaceutical research companies are now testing 691 new,medicines ... or diseases that are among the top 10 ...
... 49th annual meeting recombinant factor, VIIa-albumin fusion protein ... treatment option for hemophilia patients with ... the,results of a pre-clinical study that show for the first ... human albumin, prolonging the,half- life of this therapeutic protein while ...
Cached Medicine Technology:New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 2New Report Offers Hope for Closing Health Gap for African Americans, With Nearly 700 Medicines in Pipeline 3CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity 2CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity 3
(Date:1/22/2015)... January 22, 2015 Padre Murphy's and Owner ... of Pro Player Health Alliance (PPHA). The PPHA's ... in getting everyone, including NFL greats, treated for obstructive sleep ... leading groups supporting the cause in the valley. The most ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, ... dresses. View website of AngelWeddingDress.com to find ... wedding dresses online for a bridal party. AngelWeddingDress offers ... for them. Its maternity wedding dresses are specially designed ...
(Date:1/22/2015)... 2015 Autocarinsurancebest.com has released a new blog ... auto insurance policy . , Auto insurance quotes help ... is no longer necessary to call an agent or visit ... online on a single website: http://autocarinsurancebest.com/ . , Every ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 EBSCO Information ... (AMA) are expanding their relationship in an effort to further ... the world. While EBSCO has long made AMA journals available ... sales agent for The JAMA Network. , Long ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... , CARY, N.C., Nov. 13 Cornerstone Therapeutics Inc. ... acquiring, developing and commercializing significant products primarily for the ... appointed Andrew K. W. Powell, Esq. Executive Vice President, ... Powell will join the Company,s executive management team and ...
... ... independent clinical study on Vemma, its physician formulated liquid supplement, has ... 57, Number 19, October 14, 2009). The clinical study entitled, ... in Humans” found that Vemma is highly bioavailable, showing an increase ...
... ... Center for Wellbeing, the subscription course is aimed at optimizing health goals , ... Draper, UT (PRWEB) November ... wellness program called ZriiAware: Grow Younger, Live Longer , with the intention of ...
... Nov. 12 Regence BlueCross BlueShield has been recognized ... Heart Association,s Start! movement for helping employees eat better ... wellness are important priorities at Regence," said Mark Ganz, ... best workplace environment possible and helping our employees lead ...
... Here are highlights from the November issue of ... publication as often as you wish. Mayo ... Reprinting is allowed for a fee. Include the ... www.bookstore.mayoclinic.com or call toll-free for ...
... 12 Pregis Corporation, a leading international manufacturer, marketer, ... solutions, today announced its 2009 third quarter financial results. ... the Company generated net sales of $207.0 million, a ... in the third quarter of 2008. Excluding the impact ...
Cached Medicine News:Health News:Cornerstone Therapeutics Appoints General Counsel 2Health News:Cornerstone Therapeutics Appoints General Counsel 3Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 2Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 3Health News:Independent Clinical Study Finds Vemma is Highly Bioavailable Showing Increase in Vitamins and Antioxidants in the Blood* 4Health News:Zrii Implements New Online Lifestyle Program, ZriiAware: Grow Younger, Live Longer 2Health News:Regence Recognized as an American Heart Association Start! Fit-Friendly Company 2Health News:Regence Recognized as an American Heart Association Start! Fit-Friendly Company 3Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 2Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 3Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 4Health News:November 2009 Mayo Clinic Women's HealthSource Highlights Reducing Cancer Risk, Tips to Reduce Flatulence and Eating Nuts for Heart Health 5Health News:Pregis Announces Third Quarter 2009 Financial Results 2Health News:Pregis Announces Third Quarter 2009 Financial Results 3Health News:Pregis Announces Third Quarter 2009 Financial Results 4Health News:Pregis Announces Third Quarter 2009 Financial Results 5Health News:Pregis Announces Third Quarter 2009 Financial Results 6Health News:Pregis Announces Third Quarter 2009 Financial Results 7Health News:Pregis Announces Third Quarter 2009 Financial Results 8Health News:Pregis Announces Third Quarter 2009 Financial Results 9Health News:Pregis Announces Third Quarter 2009 Financial Results 10Health News:Pregis Announces Third Quarter 2009 Financial Results 11Health News:Pregis Announces Third Quarter 2009 Financial Results 12Health News:Pregis Announces Third Quarter 2009 Financial Results 13Health News:Pregis Announces Third Quarter 2009 Financial Results 14Health News:Pregis Announces Third Quarter 2009 Financial Results 15Health News:Pregis Announces Third Quarter 2009 Financial Results 16
Inquire...
Protects skin from corrosive drainage with the standard wear, FlexWear skin barrier. Extra Security with porous tape....
... over extended wearing time from ... is the barrier of choice ... and confidence assured with internal ... valve that allows regulation of ...
Inquire...
Medicine Products: